NCT05992896 - A Study of Loco-Regional Liposomal Bupivacaine Injection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 26, 2023

Primary Completion Date

May 15, 2025

Study Completion Date

June 30, 2025

Conditions

Peripheral Arterial Disease

Interventions

DRUG

Bupivacaine liposome

Injection into pelvic area and into the edges of wound at the end of the procedure.

DRUG

Placebo

Looks exactly like the study drug, but contains no active ingredients. Injection into pelvic area and into the edges of wound at the end of the procedure .

Trial Locations (1)

54703

Mayo Clinic Health System - Eau Claire, Eau Claire